These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37556502)

  • 1. Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines.
    Shepherd SJ; Han X; Mukalel AJ; El-Mayta R; Thatte AS; Wu J; Padilla MS; Alameh MG; Srikumar N; Lee D; Weissman D; Issadore D; Mitchell MJ
    Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2303567120. PubMed ID: 37556502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Status and Future Perspectives on MRNA Drug Manufacturing.
    Webb C; Ip S; Bathula NV; Popova P; Soriano SKV; Ly HH; Eryilmaz B; Nguyen Huu VA; Broadhead R; Rabel M; Villamagna I; Abraham S; Raeesi V; Thomas A; Clarke S; Ramsay EC; Perrie Y; Blakney AK
    Mol Pharm; 2022 Apr; 19(4):1047-1058. PubMed ID: 35238565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device.
    Shepherd SJ; Warzecha CC; Yadavali S; El-Mayta R; Alameh MG; Wang L; Weissman D; Wilson JM; Issadore D; Mitchell MJ
    Nano Lett; 2021 Jul; 21(13):5671-5680. PubMed ID: 34189917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-printed microfluidic device for high-throughput production of lipid nanoparticles incorporating SARS-CoV-2 spike protein mRNA.
    Lin WS; Bostic WKV; Malmstadt N
    Lab Chip; 2024 Jan; 24(2):162-170. PubMed ID: 38165143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Basic Method for Formulating mRNA-Lipid Nanoparticle Vaccines in the Lab.
    Jarzebska NT; Frei J; Mellett M; Kündig TM; Pascolo S; Reichmuth AM
    Methods Mol Biol; 2024; 2786():237-254. PubMed ID: 38814398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection.
    Takanashi A; Pouton CW; Al-Wassiti H
    Mol Pharm; 2023 Aug; 20(8):3876-3885. PubMed ID: 37491979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases.
    Pilkington EH; Suys EJA; Trevaskis NL; Wheatley AK; Zukancic D; Algarni A; Al-Wassiti H; Davis TP; Pouton CW; Kent SJ; Truong NP
    Acta Biomater; 2021 Sep; 131():16-40. PubMed ID: 34153512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications.
    Lopes C; Cristóvão J; Silvério V; Lino PR; Fonte P
    Expert Opin Drug Deliv; 2022 Oct; 19(10):1381-1395. PubMed ID: 36223174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
    Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
    Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating Lipid Nanoparticles with Histidinamide-Conjugated Cholesterol for Improved Intracellular Delivery of mRNA.
    Jung O; Jung HY; Thuy LT; Choi M; Kim S; Jeon HG; Yang J; Kim SM; Kim TD; Lee E; Kim Y; Choi JS
    Adv Healthc Mater; 2024 Jun; 13(14):e2303857. PubMed ID: 38344923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines.
    Han X; Alameh MG; Butowska K; Knox JJ; Lundgreen K; Ghattas M; Gong N; Xue L; Xu Y; Lavertu M; Bates P; Xu J; Nie G; Zhong Y; Weissman D; Mitchell MJ
    Nat Nanotechnol; 2023 Sep; 18(9):1105-1114. PubMed ID: 37365276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a high-throughput platform for screening lipid nanoparticles for mRNA delivery.
    Cui L; Pereira S; Sonzini S; van Pelt S; Romanelli SM; Liang L; Ulkoski D; Krishnamurthy VR; Brannigan E; Brankin C; Desai AS
    Nanoscale; 2022 Jan; 14(4):1480-1491. PubMed ID: 35024714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low energy nebulization preserves integrity of SARS-CoV-2 mRNA vaccines for respiratory delivery.
    van Rijn CJM; Vlaming KE; Bem RA; Dekker RJ; Poortinga A; Breit T; van Leeuwen S; Ensink WA; van Wijnbergen K; van Hamme JL; Bonn D; Geijtenbeek TBH
    Sci Rep; 2023 May; 13(1):8851. PubMed ID: 37258559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-Catalyzed One-Step Synthesis of Ionizable Cationic Lipids for Lipid Nanoparticle-Based mRNA COVID-19 Vaccines.
    Li Z; Zhang XQ; Ho W; Li F; Gao M; Bai X; Xu X
    ACS Nano; 2022 Nov; 16(11):18936-18950. PubMed ID: 36269150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and Evaluation of Nucleoside-Modified mRNA Vaccines for Infectious Diseases.
    Vadovics M; Muramatsu H; Sárközy A; Pardi N
    Methods Mol Biol; 2024; 2786():167-181. PubMed ID: 38814394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of mixing and shaking on mRNA-LNP drug product quality characteristics.
    Matthessen R; Van Pottelberge R; Goffin B; De Winter G
    Sci Rep; 2024 Aug; 14(1):19590. PubMed ID: 39179645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery.
    Maeki M; Uno S; Niwa A; Okada Y; Tokeshi M
    J Control Release; 2022 Apr; 344():80-96. PubMed ID: 35183654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA).
    Álvarez-Benedicto E; Farbiak L; Márquez Ramírez M; Wang X; Johnson LT; Mian O; Guerrero ED; Siegwart DJ
    Biomater Sci; 2022 Jan; 10(2):549-559. PubMed ID: 34904974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters.
    Deng YQ; Zhang NN; Zhang YF; Zhong X; Xu S; Qiu HY; Wang TC; Zhao H; Zhou C; Zu SL; Chen Q; Cao TS; Ye Q; Chi H; Duan XH; Lin DD; Zhang XJ; Xie LZ; Gao YW; Ying B; Qin CF
    Cell Res; 2022 Apr; 32(4):375-382. PubMed ID: 35210606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.